Pfizer

Pfizer's New Focus: Can Cancer Drugs Become the Next Big Moneymaker for Investors?

Pfizer is prepared to move on from Covid. Following a challenging year characterized by the sharp drop of its Covid business, the company is now placing its bets on cancer medications to help it regain its footing.

Did Pfizer Forget How to Make Money Without a Pandemic?

In a few years, a lot can happen in the stock market, and Pfizer is a prime example. By the end of 2021, the COVID-19 vaccine manufacturer was doing well, with its shares trading at about $60. In 2022, it would break the record with an annual revenue of above $100 billion.

FedEx, UPS are Rivals that Choose to Work Together in Delivering the Coronavirus Vaccine

FedEx, UPS Rivals Work Together to Deliver Coronavirus Vaccine

FedEx and UPS are two fierce competitors companies who came up with a plan of dividing the United States to ensure that the COVID-19 vaccines will be delivered as quickly as possible.

Global Vaccine Market to Reach $54.15 Billion by 2027

The global vaccine market generated $32.46 billion in 2019 and is expected to reach $54.15 by 2027.

Pfizer COVID-19 Vaccine Data Shows 90 Percent Effective Rate

Could Buying Pfizer Stocks Make You Millionaire?

Here are further reasons why you should buy Pfizer stock other than its COVID-19 vaccine.

FDA Grants Priority Tag to Pfizer Pneumococcal Vaccine, Company Could Gain Billions in Revenue

Pfizer Inc. announced that the Food and Drug Association (FDA) granted priority review to its biologics license application that seeks approval for its 20-valent pneumococcal conjugate vaccines for adults amid company's stock shares soar.

Stock Futures Soar 1,700+ Points After Pfizer Announces Trial Vaccine 90% Effective

Stock Futures Soar 1,700+ Points After Pfizer Announces Trial Vaccine is 90% Effective

Stock futures surged before the markets opened following drugmaker Pfizer says a new COVID-19 vaccine shows an excellent promise in late-stage testing.

Alibaba Hired Top Counterfeit Investigator

Alibaba Holding hired Matthew Bassiur to remove counterfeit product off its site and maintain Alibaba reputation as a global marketplace.

The biggest pharma deal ever nears completion; Pfizer and Allergan close to seal merger

Pfizer Inc. and Allergan Plc may announce an agreement as early as Monday after its board of directors are expected to vote regarding the deal on Sunday. The deal, valued at more than $150 billion, would be the largest pharmaceutical merger in history.

Pfizer-Allergan merger deal advances

Pfizer Inc. is in advanced talks to buy Allergan Plc which could be the largest drug merger in the US history. The deal will see Pfizer buying Allergan for as much as $380 per share valuing the company at a total of $150 billion.

Pfizer has been shifting profits overseas longer than most think

Pfizer's plan to acquire Allergen is getting much criticisms since it would mean the giant drug company's headquarters and taxable profits to Ireland.

Pfizer and Allergan is in talk for a merger

Pfizer and Allergan are currently in a preliminary stage for the biggest merger deal in the pharmaceutical industry. However, there are still lots of problems that need to be solve including the tax inversion accusation made by politicians in the US.

Latest Stories

Over 25% of US Consumers Earning Below $50,000 Avoid Fast Food Due to High Cost

According to a January survey conducted by consulting company Revenue Management Solutions, over 25% of those with incomes under $50,000 were reducing their use of fast food, citing expense as a reason.

Strong US Economy Masks Struggles of Low-Income Consumers

One of the primary foundations preventing the U.S. economy from entering a recession-resilient family spending-is beginning to show signs of weakness.

Trump's Second Presidency Could Spell Gains for Crypto, NFTs

Geoff Kendrick, the head of FX Research and Digital Assets Research at Standard Chartered Bank, suggests that a win by former U.S. President Donald Trump in the upcoming November U.S. presidential election could have a positive impact on Bitcoin.

TikTok Ban on Hold? App Fights for 170 Million US Users

On Tuesday, TikTok and its Chinese parent firm ByteDance filed a lawsuit in a U.S. federal court, attempting to overturn a bill that President Joe Biden had signed that would have required the 170 million Americans who use the short video app to either divest or outright prohibit it.

SEC Chair Gary Gensler Deems Crypto a Central Player in Market Issues

U.S. Securities and Exchange Commission (SEC) Chairman Gary Gensler covered a variety of subjects, including cryptocurrencies.

Must Read

Second Chance for FTX? Exchange Offers Full Repayment Plus Compensation to Creditors

FTX intends to fully repay the remaining creditors plus pay them "billions in compensation for the time value of their investments," leaving 98% of its creditors with up to 118% of their permitted claims.

Equinox’s Ultra-Pricey Program Aims to Extend Your Life

Equinox, a high-end fitness business, is charging for the ultimate luxury: longer life. The business unveiled a subscription on Monday that, at a whopping $36,000 annually, entitles users to more than 100 tests designed to improve health and lengthen life.

Can a $22,000 All-Inclusive Resort Live Up to the Hype?

According to a JLL Research Hotels & Hospitality research, demand for all-inclusive resorts surged after the pandemic. The study found that suddenly, many travelers desired stress-free, simple-to-plan trips, ideally with a health focus.

Crypto Price Predictions for 2026: Bitcoin, Ethereum, Option2Trade Will Increase Value

In the cryptocurrency industry, the forecast that Bitcoin (BTC) will reach $500,000 by 2026 embodies optimistic confidence. Several variables support this enormous price objective, which analysts predict will increase Bitcoin's value.

Crypto Giant Kraken Makes Waves in Europe with New German Deal

By revealing a new strategic alliance that will allow Kraken to actively improve its product offering in Germany, a crucial market for the adoption of cryptocurrencies in Europe, Kraken is doubling down on its goal of expanding throughout the continent.

Stay Connected with Money Times

` `